MétaCan
Menu
← Back to cohort

Does early phase study enrollment for pediatric oncology patients have an impact on symptom burden and quality of life (QOL)? A national Canadian study report.

2025· article· en· W4410803189 on OpenAlexaffabout
Kendra Rodden, Isabelle Laforest, Rebecca Deyell, Victor Lewis, Sunil Desai, Cielle Stapleton, Carol Portwine, Vicky R. Breakey, Alexandra P. Zorzi, Lillian Sung, Monia Marzouki, Catherine Goudie, Meghan Pike, Lamia Hayawi, Nick Barrowman, Donna L. Johnston, Nirav Thacker, Antonia Palmer, Jason N. Berman, Lesleigh S. Abbott

Bibliographic record

VenueJournal of Clinical Oncology · 2025
Typearticle
Languageen
FieldMedicine
TopicChildhood Cancer Survivors' Quality of Life
Canadian institutionsIWK FoundationMontreal Children's HospitalCentre Hospitalier Universitaire Sainte-JustineLondon Health Sciences CentreMcMaster Children's HospitalMcMaster UniversityCancerCare ManitobaHospital for Sick ChildrenStollery Children's HospitalAlberta Children's HospitalChildren's Hospital of Eastern OntarioUniversity of CalgaryBC Children's Hospital
Fundersnot available
KeywordsMedicineQuality of life (healthcare)Pediatric oncologyCancerGerontologyFamily medicineInternal medicineNursing

Abstract

fetched live from OpenAlex

10023 Background: There are few therapeutic options for pediatric patients with relapsed or refractory cancers. The impact of early phase trial enrolment on the quality of life (QOL) and symptom burden in this patient population is unknown. We hypothesized that this information could inform future clinical trial design and would be of value to clinicians, patients and their families. The primary aim was to determine if those enrolled on a phase I or II trial had improved QOL measured using the PedsQL 3.0 Acute cancer Module compared to those eligible, not not enrolled on a trial. Methods: In this Canadian multi-site study, we included patients 2-18 years of age who were enrolled on a phase I/II clinical trial and those who would have been eligible but did not enroll. The PedsQL 3.0 Acute Cancer Module was completed at baseline, week 4 and week 8 by guardians and by patients, for those age 5 and older. The PedsQL 3.0 Acute Cancer Module total scores were compared separately for patients and guardians using a mixed linear registration model with a random effect for a patient. Results: Of the 80 patients, 31 (39%) patients were enrolled on an early phase trial and 49 (61%) were not enrolled. The majority of patients had a brain tumor (63.3% of those enrolled; 32.7% of those not), followed by a bone tumor (16.7% of those enrolled; 24.5% of those not). In both groups, the majority of patient were included at the time of their first relapse (64.5% of those enrolled and 69.9% of those not). No significant difference was found between PedsQL3.0 patients or guardians; p = 0.09). The PedsQL3.0 total scores were significantly higher for patients enrolled on an early phase trial compared to those patients not enrolled (p = 0.01). However, after adjusting for baseline levels, the difference between enrolled patients vs not was not statistically significant (p = 0.8). Conclusions: Being enrolled on an early phase trial does not appear to have a negative effect on one's quality of life. The results have also demonstrated that it is feasible to evaluate patients enrolled and not enrolled on early phase trials and compare their symptom experience using the PedsQL 3.0 Acute cancer Module. Continued efforts will focus on more recruitment and using SSPedi to further investigate differences in QOL. This research is supported through C17 Council, Kindred Foundation and the CHEO Research Institute.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.013
metaresearch head score (Gemma)0.022
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.979
Threshold uncertainty score0.151

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0130.022
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.002
Bibliometrics0.0010.004
Science and technology studies0.0020.001
Scholarly communication0.0020.001
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0050.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.173
GPT teacher head0.568
Teacher spread0.395 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueJournal of Clinical Oncology→Same topicChildhood Cancer Survivors' Quality of Life→French-language works237,207→